These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6969730)

  • 21. Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.
    Körfer A; Kirchner H; Schneekloth C; Bührer C; Wisniewski D; Gulati S; Clarkson B; Knowles R; Poliwoda H; Atzpodien J
    Acta Haematol; 1989; 82(4):193-6. PubMed ID: 2511721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of normal myeloid-associated antigens by acute leukemia cells.
    Dinndorf PA; Andrews RG; Benjamin D; Ridgway D; Wolff L; Bernstein ID
    Blood; 1986 Apr; 67(4):1048-53. PubMed ID: 2937468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane marker analysis of 'lymphoid' and myeloid blast crisis in PH1 positive (chronic myeloid) leukemia.
    Janossy G; Greaves MF; Capellaro D; Roberts M; Goldstone AH
    Haematol Blood Transfus; 1977; 20():97-107. PubMed ID: 305406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of five human malignant non-T lymphoid cell lines and mixed lymphocyte-tumor reaction.
    Minegishi M; Tsuchiya S; Minegishi N; Konno T
    Tohoku J Exp Med; 1987 Mar; 151(3):283-92. PubMed ID: 2954268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies.
    Herrmann F; Dörken B; Ludwig WD; Schwarting R
    Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemic myeloblasts expressing lymphoid markers.
    Reizenstein P; Beksac M; Biberfeld P; Christensson B; Lagerlöf B; Laurén L; Ost A; Porwit A
    Acta Haematol; 1985; 74(3):148-50. PubMed ID: 2937254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
    Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
    Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignancies.
    Bardales RH; Al-Katib AM; Carrato A; Koziner B
    J Histochem Cytochem; 1989 Jan; 37(1):83-9. PubMed ID: 2491755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia.
    Pui CH; Raimondi SC; Behm FG; Ochs J; Furman WL; Bunin NJ; Ribeiro RC; Tinsley PA; Mirro J
    Blood; 1986 Dec; 68(6):1306-10. PubMed ID: 2946333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage.
    Iizasa T; Yamaguchi Y; Tagawa M; Fujisawa T; Saito H; Kondo H; Matsuo Y; Minowada J; Taniguchi M
    Jpn J Cancer Res; 1991 Feb; 82(2):213-8. PubMed ID: 1900825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelo-monocytic differentiation potential of the CALLA-positive Nalm 6M1 cell line.
    Lau B; Jäger G; Lippl U
    Eur J Haematol; 1987 Feb; 38(2):156-61. PubMed ID: 2954849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
    Minowada J; Tsubota T; Greaves MF; Walters TR
    J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of antigens on acute lymphoblastic leukemias.
    Rodt H; Netzel B; Thiel E; Hoffmann-Fezer G; Thierfelder S
    Haematol Blood Transfus; 1979; 23():347-52. PubMed ID: 317475
    [No Abstract]   [Full Text] [Related]  

  • 34. Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies.
    Fried J; Perez AG; Shimazaki C; Clarkson BD
    Exp Cell Biol; 1987; 55(6):322-30. PubMed ID: 2453381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).
    Kimby E; Axelsson B; Björkholm M; Gordon J; Holm G; Mellstedt H
    Med Oncol Tumor Pharmacother; 1985; 2(4):261-7. PubMed ID: 2935687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections.
    Hansmann ML; Wacker HH; Gralla J; Lumbeck H; Kossmahl M; Heidebrecht HJ; Radzun HJ; Parwaresch MR
    Blood; 1991 Feb; 77(4):809-17. PubMed ID: 1704265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute leukemias with both myeloid and lymphoid surface markers. Cytoplasmic alpha-1-anti-chymotrypsin and alpha-1-anti-trypsin as possible indicators of early granulocytic differentiation.
    Meyer PR; Krugliak L; Neely S; Levine A; Parker JW; Kaplan B; Taylor CR
    Am J Clin Pathol; 1986 Oct; 86(4):461-8. PubMed ID: 2945424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
    Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE
    Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas.
    Foon KA
    Curr Probl Cancer; 1989; 13(2):57-128. PubMed ID: 2659257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double immunoenzymatic labeling of lymphomatous tissues for both immunologic phenotype and a malignancy-associated nucleolar antigen.
    Lu M; Davis FM; Ford RJ
    Am J Pathol; 1986 Apr; 123(1):73-8. PubMed ID: 2421582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.